NICHD
Investigators Urge Additional Screening to Catch Maternal Cancer From Nonreportable NIPT Results
An NIH team detected maternal cancers in nearly half of individuals with unusual or nonreportable findings from cell-free DNA-based fetal aneuploidy tests.
Early IDENTIFY Trial Results Suggest Half of Women With Non-Reportable NIPT Result Have Cancer
At the American College of Medical Genetics and Genomics annual meeting, NICHD Director Diana Bianchi reported that whole-body MRI was the best follow-up test to confirm or rule out cancer.
Type 2 Diabetes Risk for Women With Gestational Diabetes is Increased by Genetic Factors
A high genetic risk score was associated with increased risk of developing type 2 diabetes in both a US and a Danish cohort of women with gestational diabetes.
All of Us Research Program, NICHD Team Up for Pregnancy Study
The pilot seeks to enroll 100 All of Us participants who are pregnant into the ongoing NICHD's PregSource initiative, which collects patient-reported data.
HudsonAlpha Wins $12.4M in NIH Grants for Population Genomics, Pediatric Sequencing
The institute will apply long-read sequencing to the NIH All of Us program and conduct pediatric sequencing for cancer and birth defect studies.